Said Sebti

Said Sebti (, (first name () is an American cancer researcher who is Professor and Chairman of the Department of Drug Discovery at the H. Lee Moffitt Cancer Center & Research Institute in Tampa, Fl. Sebti is noted for his work to rehabilitate the 'failed' cancer drug Triciribine, now under development at the pharmaceutical company Prescient Therapeutics (ASX: PTX). Sebti is currently Chief Scientific Officer at Prescient Therapeutics. Provided by Wikipedia
Showing 1 - 4 results of 4 for search 'Said Sebti', query time: 0.03s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4